Ident. | Authors (with country if any) | Title |
---|
000411 (2011) |
Kitty K. Wong [Australie] ; Jane E. Alty [Australie] ; Amanda G. Goy [Australie] ; Sanjay Raghav [Australie] ; David C. Reutens [Australie] ; Peter A. Kempster [Australie] | A randomized, double‐blind, placebo‐controlled trial of levetiracetam for dyskinesia in Parkinson's disease |
000429 (2010) |
Deborah Lehmann [Australie] ; Judith Willis [Australie] ; Hannah C. Moore [Australie] ; Carolien Giele [Australie] ; Denise Murphy [Australie] ; Anthony D. Keil [Australie] ; Catherine Harrison [Australie] ; Kathy Bayley [Australie] ; Michael Watson [Australie] ; Peter Richmond [Australie] | The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non-Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes |
000504 (2010) |
Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada] | The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates |
000512 (2010) |
Glenda Margaret Halliday [Australie] ; Heather Mccann [Australie] | The progression of pathology in Parkinson's disease |
000577 (2010) |
Ying Jiao Zhao ; Hwee Lin Wee ; Yiong-Huak Chan ; Soo Hoon Seah ; Wing Lok Au ; Puay Ngoh Lau ; Emmanuel Camara Pica ; Shu Chuen Li [Australie] ; Nan Luo ; Louis C. S. Tan | Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times |
000622 (2010) |
Evangelos Evangelou [Grèce, Suisse] ; Demetrius M. Maraganore [États-Unis] ; Grazia Annesi [Italie] ; Laura Brighina [Italie] ; Alexis Brice [France] ; Alexis Elbaz [France] ; Carlo Ferrarese [Italie] ; Georgios M. Hadjigeorgiou [Grèce] ; Rejko Krueger [Allemagne] ; Jean-Charles Lambert [France] ; Suzanne Lesage [France] ; Katerina Markopoulou [Grèce] ; George D. Mellick [Australie] ; Bram Meeus [Belgique] ; Nancy L. Pedersen [Suède] ; Aldo Quattrone [Italie] ; Christine Van Broeckhoven [Belgique] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Eng-King Tan [Singapour] ; Karin Wirdefeldt [Suède] ; John P. A. Ioannidis [Grèce, États-Unis] | Non‐replication of association for six polymorphisms from meta‐analysis of genome‐wide association studies of Parkinson's disease: Large‐scale collaborative study |
000681 (2010) |
Sean S. O'Sullivan [Royaume-Uni] ; Atbin Djamshidian [Royaume-Uni, Autriche] ; Zeshan Ahmed [Royaume-Uni] ; Andrew H. Evans [Australie] ; Andrew D. Lawrence [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Impulsive‐compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy |
000713 (2010) |
Kay Seidel [Allemagne] ; Ludger Schöls [Allemagne] ; Silke Nuber [Allemagne] ; Elisabeth Petrasch-Parwez [Allemagne] ; Kristin Gierga [Allemagne] ; Zbigniew Wszolek [États-Unis] ; Dennis Dickson [États-Unis] ; Wei P. Gai [Australie] ; Antje Bornemann [Allemagne] ; Olaf Riess [Allemagne] ; Abdelhaq Rami [Allemagne] ; Wilfried F. A. Den Dunnen [Pays-Bas] ; Thomas Deller [Allemagne] ; Udo Rüb [Allemagne] ; Rejko Krüger [Allemagne] | First appraisal of brain pathology owing to A30P mutant alpha‐synuclein |
000770 (2010) |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward |
000807 (2010) |
Gabriella Constantinescu [Australie] ; Deborah Theodoros [Australie] ; Trevor Russell [Australie] ; Elizabeth Ward [Australie] ; Stephen Wilson [Australie] ; Richard Wootton [Royaume-Uni] | Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application |
000814 (2010) |
Nadeeka N. W. Dissanayaka [Australie] ; Anna Sellbach [Australie] ; Sally Matheson [Australie] ; John D. O'Sullivan [Australie] ; Peter A. Silburn [Australie] ; Gerard J. Byrne [Australie] ; Rodney Marsh [Australie] ; George D. Mellick [Australie] | Anxiety disorders in Parkinson's disease: Prevalence and risk factors |
000830 (2010) |
Lukasz Szumowski [Pologne] ; Ewa Szufladowicz [Pologne] ; Michał Orczykowski [Pologne] ; Robert Bodalski [Pologne] ; Paweł Derejko [Pologne] ; Andrzej Przybylski [Pologne] ; Piotr Urbanek [Pologne] ; Mariusz Ku Mierczyk [Pologne] ; Edward Ko Luk [Pologne] ; Frederic Sacher [France] ; Prashanthan Sanders [Australie] ; Joanna Dangel [Pologne] ; Michel Haissaguerre [France] ; Franciszek Walczak [Pologne] | Ablation of Severe Drug‐Resistant Tachyarrhythmia During Pregnancy |
000832 (2010) |
M. Kaye Trembath [Australie] ; Zoë A. Horton [Australie] ; Lynette Tippett [Nouvelle-Zélande] ; Virginia Hogg [Nouvelle-Zélande] ; Veronica R. Collins [Australie] ; Andrew Churchyard [Australie] ; Dennis Velakoulis [Australie] ; Richard Roxburgh [Nouvelle-Zélande] ; Martin B. Delatycki [Australie] | A retrospective study of the impact of lifestyle on age at onset of Huntington disease |
000841 (2010) |
Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande] | A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease |
000886 (2009) |
Rachel Chee [Australie] ; Anna Murphy [Australie] ; Mary Danoudis [Australie] ; Nellie Georgiou-Karistianis [Australie] ; Robert Iansek [Australie] | Gait freezing in Parkinson's disease and the stride length sequence effect interaction |
000905 (2009) |
Mark D. Latt ; Hylton B. Menz ; Victor S. Fung ; Stephen R. Lord [Australie] | Acceleration Patterns of the Head and Pelvis During Gait in Older People With Parkinson's Disease: A Comparison of Fallers and Nonfallers |
000906 (2009) |
M. Selikhova [Royaume-Uni, Russie] ; D. R. Williams [Royaume-Uni, Australie] ; P. A. Kempster [Royaume-Uni, Australie] ; J. L. Holton [Royaume-Uni] ; T. Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | A clinico-pathological study of subtypes in Parkinson's disease |
000930 (2009) |
Laura Silveira-Moriyama [Royaume-Uni] ; Aviva Petrie [Royaume-Uni] ; David R. Williams [Australie] ; Andrew Evans [Australie] ; Regina Katzenschlager [Autriche] ; Egberto R. Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | The use of a color coded probability scale to interpret smell tests in suspected parkinsonism |
000973 (2009) |
Linda Truong [Australie] ; Daniel Brooks [Australie] ; Fabricio Amaral [Australie] ; Jasmine M. Henderson [Australie] ; Glenda M. Halliday [Australie] | Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia |
000A32 (2009) |
Prachi Mehta [Australie] ; George D. Mellick [Australie] ; Dominic B. Rowe [Australie] ; Glenda M. Halliday [Australie] ; Michael M. Jones [Australie] ; Neil Manwaring [Australie] ; Himesha Vandebona [Australie] ; Peter A. Silburn [Australie] ; Jie Jin Wang [Australie] ; Paul Mitchell [Australie] ; Carolyn M. Sue [Australie] | Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community |
000A62 (2009) |
Andrew H. Evans [Australie] ; Antonio P. Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis] | Impulsive and compulsive behaviors in Parkinson's disease |